Overview

Efficacy Study of Iferanserin to Treat Hemorrhoids

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of topical 0.5% S-MPEC cream vs. placebo cream (applied twice daily for 14 days) in the treatment of Grade I - III hemorrhoids.
Phase:
Phase 2
Details
Lead Sponsor:
Ventrus Biosciences, Inc